That's crucial, since the way a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be reliable. To put it simply, we have to understand how these proteins fold if we desire a drug to work. Historically, this has been an experimental process (jeff brown predictions for 2021). But now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're developed to do. This was a breakthrough practically nobody observed. However it's going to have profound implications for treating illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be a lot of financial investment chances in this space, too. Shifting subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (biotech stock). That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it pulled back possibly significantly prior to going greater - korean actress. I have actually been covering bitcoin for a long time now. Among the first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were mainly informing readers. But that's not the huge concern anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. exponential tech investor. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are many excellent private companies on the edge of hitting the public markets And I have actually been dealing with a brand-new method for you to invest even prior to these companies go public.
This opportunity has been developing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the details. Go right here to schedule your area totally free.
Emma Walsh here, managing editor of the Journal. Routine Journal readers know that tech isn't our normal beat (jeff brown predictions 2021). And when it concerns tech investing, we leave it to the professionals. The good news is, we have numerous such professionals in our Rolodex. Our colleague Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing experts we understand (future report). In fact, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the huge picture and predict what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and much more. These trends are experiencing exponential growth and creating incredible chances for investors. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. biotech stocks. However in spite of what lots of readers may think, this is a trend that's simply getting going. Despite the fact that the COVID-19 pandemic disrupted supply chains last year, a remarkable 250 million 5G-enabled devices were still sold.
And all of this eventually resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown stock predictions). Losing 2 months of manufacturing and sales actually impacts how lots of 5G gadgets are sold in the fiscal year. When you think about all of that, selling 250 million units is impressive. More notably, the delays caused by the pandemic created a lots of suppressed demand. Which need is now going to be pushed into 2021. In truth, I forecast that more than 500 million 5G devices will be shipped in 2021 - jeff brown predictions 2021. Which's not my only 5G prediction When I've discussed 5G in the past, I have actually explained its 3 various phases.
In Phase Two, 5G gadgets go on sale. 5G phones and other products start to reach customers. And in Stage Three, 5G services start to be used (social media). That's when we begin to see applications running on 5G networks. Believe of things like enormous multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Stage Three by this summertime. This begins something of a virtuous cycle: The majority of people do not really appreciate the technology. But they will care if there are exciting applications that can only be accessed with a 5G phone.
That causes more 5G apps being developed. In reality, 5G is going to open up a suite of incredible applications: self-driving vehicles, the Internet of Things, robotic surgical treatment, and more. All of these technologies need 5G. The investment chances going forward will be enormous. Stepping away from 5G, the next important innovation I visualize in 2021 is CRISPR genetic editing. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. However it's one of the most exciting developments in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software.
The program can crash or not operate correctly. CRISPR uses a similar concept but with our hereditary code. "Typos" in our genome can result in disease. CRISPR can remedy these "typos." For many years, CRISPR was mainly a specific niche technology that wasn't well understood. And throughout that time, there were actually only three business running in this space. However things are altering. CRISPR is no longer just theoretical. We're seeing real results. We're dealing with illness and seeing that this technology just works. And as a result, a "second crop" of early-stage CRISPR business is going public and delivering incredible returns. This entire market is effectively a greenfield chance.
There's room for numerous business to exist in this space. jeff brown investment prediction. And there will be more. That's my forecast for CRISPR in 2021. I predict that 2 or three more hereditary modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things happening at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its most current Alpha, Fold software can precisely anticipate the folding of a protein based entirely on its amino acid sequence with 92. 4% accuracy. That's important since the method a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been a trial-and-error procedure. But now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one but numerous drug treatments produced utilizing this technology. This was one of those breakthroughs that practically nobody observed. But it's going to have extensive ramifications for curing illness. And, of course, there will be a lot of investment opportunities in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be shocked if it drew back possibly considerably prior to going greater. I've been covering bitcoin for a long time now. One of the very first research study reports I ever published was on bitcoin - what is the legacy report predicting. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for any person who followed my recommendation. But at the time of that initial suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
But no one is asking that concern any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. social media. Mass, Mutual is a 150-year-old institution. So believe about that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the details is up to date as of February 2021, but we could not separately confirm this claim. Given Jeff Brown's past, he likely has a significant net worth, however we can't hammer down a precise figure at this moment. Brown is best known for his sage-like capability to pick winning technology stocks. He invested more than 25 years researching technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an outstanding point of view on the market. He's always on the hunt for brand-new chances, and he shares numerous of his best choices in the Future Report.
That's high appreciation, however it's not ridiculously reasoned. Brown has an outstanding credibility as a stock-picker, and he effectively anticipated some of the most significant financial occasions of the past 20 years. Although he doesn't appear to launch his picks to the public, the service's success is a direct sign of Brown's stock-picking prowess. No one on Wall Street gets it right whenever, however Jeff Brown's accurate forecasts have earned him legions of devoted fans. That states a lot about his ability. The Near Future Report is published by Brownstone Research, a prominent monetary research study publisher. Brownstone Research offers a number of research study services with a wide range of specializations - tech stocks.
The business is likewise connected with Bonner & Partners, another well-respected research publisher - social media. On its site, Brownstone says its objective is to offer retail investors with professional-grade research study: "For too long, the very best investment research study has actually not been offered to private financiers. It has been usually booked for financial investment banks, hedge funds, personal equity, and high-net-worth clients. genetic sequencer stock jeff brown. The mission of Brownstone Research study is to make that type of exclusive research offered to any investors wanting to acquire an edge in the markets. The objective is basic to provide unique and profitable financial investment research study found no place else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise works as the company's Chief Financial investment Expert.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to use its clients. After decades of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout most of America. If you know even a bit about the marketplace, you know that he has a track record as a King Midas of sorts. brownstone research stock. Whatever he touches relies on gold! Jeff is well mindful of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big job.
In truth, Brown thinks S.A.V. jeff brown stock predictions 2021. might be "the biggest pattern of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be weding 2 advanced technologies: artificial intelligence and electric vehicles. Musk hopes the combination will assist him establish the first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing except the automobile market's Holy Grail. As you understand, electrical cars and self-driving cars and truck stocks have actually been big this year, however the Wall Street device has been big on hype without much tangible result. Despite a drastic increase in competitors over the previous few years, Brown still thinks Musk has the best chance of putting all of it together.
tech might be the magic string that connects it all together. S.A.V. represents Shared Autonomous Automobile, and it might be the future of transport. Basically, this technology would allow you to rent your cars and truck as a self-governing, self-driving taxi when you're not utilizing it. You merely get out of the car and press a button on an app that informs the automobile to "sign up with the fleet." Next thing you understand, you're unwinding on your sofa while your car shuttles ride-sharers around town. Best of all, you get to keep a substantial piece of the earnings. It sounds crazy, however it could be closed than you believe.